+ Follow ARGUS BIOMEDICAL PTY LTD Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 183953
[Title] => Hope for corneal blindness
[Summary] => People suffering from corneal blindness are to be given a second chance at sight, thanks to an Australian bio-medical eye company which has developed an international first an artificial cornea.
Argus Biomedical Pty Ltd. was recently given approval by the US Food and Drug Administration (FDA) to sell the first soft artificial cornea, the AlphaCor, in the United States.
The FDA endorsement complements regulatory approval for AlphaCor in Europe, Canada and Australia, and a product development program which commenced in 1989.
[DatePublished] => 2002-11-14 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
ARGUS BIOMEDICAL PTY LTD
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 183953
[Title] => Hope for corneal blindness
[Summary] => People suffering from corneal blindness are to be given a second chance at sight, thanks to an Australian bio-medical eye company which has developed an international first an artificial cornea.
Argus Biomedical Pty Ltd. was recently given approval by the US Food and Drug Administration (FDA) to sell the first soft artificial cornea, the AlphaCor, in the United States.
The FDA endorsement complements regulatory approval for AlphaCor in Europe, Canada and Australia, and a product development program which commenced in 1989.
[DatePublished] => 2002-11-14 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
November 14, 2002 - 12:00am